Samir Koirala

Company: Biogen

Job title: Director of Research, Genetic & Neurodevelopmental Disorders Unit

Seminars:

Symptomatic vs Genetic Disease Modifying Treatments 9:10 am

Most industry portfolios reflect either a strategic balance between, or unitary commitment to either small molecule or genetic modalities for engaging targets involved in the biological processes implicated in rare diseases of the central nervous system. This panel will explore key strategic, technical, and scientific considerations shaping these decisions. • How can we assess benefit/risk…Read more

day: Day One